Anúncio
Anúncio
RGNX
REGENXBIO Inc.
14.57
USDPatrocinado
-0.43
-2.85%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
15.02
+0.44
+3.04%
Relatórios de Lucros RGNX
Rácio de surpresa positiva
RGNX separação 16 de 40 últimas estimativas.
40%
Próximo Relatório
Data do Próximo Relatório
11 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$50.48M
/-$0.85
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+69.79%
/-29.17%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+137.97%
/-15.84%
REGENXBIO Inc. earnings per share and revenue
On 06 de nov. de 2025, RGNX reported earnings of -1.20 USD per share (EPS) for Q3 25, beating the estimate of -1.33 USD, resulting in a 9.88% surprise. Revenue reached 29.73 milhão, compared to an expected 24.61 milhão, with a 20.83% difference. The market reacted with a -3.79% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 analistas forecast an EPS of -0.85 USD, with revenue projected to reach 50.48 milhão USD, implying an diminuir of -29.17% EPS, and aumentar of 69.79% in Revenue from the last quarter.
FAQ
What were REGENXBIO Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, REGENXBIO Inc. reported EPS of -$1.20, beating estimates by 9.88%, and revenue of $29.73M, 20.83% above expectations.
How did the market react to REGENXBIO Inc.'s Q3 2025 earnings?
The stock price moved down -3.79%, changed from $11.61 before the earnings release to $11.17 the day after.
When is REGENXBIO Inc. expected to report next?
The next earning report is scheduled for 11 de mar. de 2026.
What are the forecasts for REGENXBIO Inc.'s next earnings report?
Based on 14
analistas, REGENXBIO Inc. is expected to report EPS of -$0.85 and revenue of $50.48M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio